Cooper Investors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.97M | Sell |
27,046
-19,506
| -42% | -$5.4M | 2.74% | 15 |
|
|
2026
Q1 | $13.7M | Sell |
46,552
-4,201
| -8% | -$1.25M | 5.6% | 3 |
|
|
2025
Q4 | $13.9M | Sell |
50,753
-3,180
| -6% | -$864K | 4.61% | 6 |
|
|
2025
Q3 | $14.6M | Sell |
53,933
-51,872
| -49% | -$14.1M | 3.98% | 7 |
|
|
2025
Q2 | $29.2M | Sell |
105,805
-21,508
| -17% | -$5.85M | 5.31% | 3 |
|
|
2025
Q1 | $33.8M | Sell |
127,313
-6,596
| -5% | -$1.63M | 5.49% | 3 |
|
|
2024
Q4 | $31.1M | Sell |
133,909
-27,572
| -17% | -$6.34M | 4.9% | 5 |
|
|
2024
Q3 | $35.6M | Buy |
161,481
+4,647
| +3% | +$962K | 5.3% | 4 |
|
|
2024
Q2 | $30.8M | Sell |
156,834
-144,236
| -48% | -$29.8M | 4.69% | 6 |
|
|
2024
Q1 | $64.8M | Buy |
301,070
+227,469
| +309% | +$47.8M | 3.74% | 13 |
|
|
2023
Q4 | $15.5M | Buy |
73,601
+60,329
| +455% | +$12.9M | 0.93% | 26 |
|
|
2023
Q3 | $2.46M | Buy |
+13,272
| New | +$2.64M | 0.2% | 31 |
|
|
2023
Q1 | $2.32M | Buy |
12,136
+2,879
| +31% | +$521K | 0.2% | 30 |
|
|
2022
Q4 | $1.56M | Buy |
9,257
+570
| +7% | +$99.1K | 0.15% | 34 |
|
|
2022
Q3 | $1.54M | Buy |
8,687
+3,616
| +71% | +$715K | 0.15% | 32 |
|
|
2022
Q2 | $1.04M | Hold |
5,071
| – | – | 0.09% | 29 |
|
|
2022
Q1 | $1.21M | Sell |
5,071
-153
| -3% | -$35.9K | 0.08% | 29 |
|
|
2021
Q4 | $1.19M | Sell |
5,224
-190,915
| -97% | -$42M | 0.08% | 34 |
|
|
2021
Q3 | $37.9M | Buy |
196,139
+42,779
| +28% | +$8.67M | 2.51% | 18 |
|
|
2021
Q2 | $32.6M | Hold |
153,360
| – | – | 2.14% | 22 |
|
|
2021
Q1 | $31.3M | Sell |
153,360
-96,651
| -39% | -$19M | 2.33% | 20 |
|
|
2020
Q4 | $45.5M | Buy |
250,011
+8,539
| +4% | +$1.45M | 3.63% | 13 |
|
|
2020
Q3 | $40.4M | Buy |
241,472
+42,040
| +21% | +$7.08M | 3.77% | 12 |
|
|
2020
Q2 | $32.4M | Buy |
199,432
+25,714
| +15% | +$4.61M | 3.37% | 11 |
|
|
2020
Q1 | $30M | Sell |
173,718
-26,130
| -13% | -$5.2M | 3.77% | 11 |
|
|
2019
Q4 | $40.1M | Buy |
199,848
+1,192
| +0.6% | +$245K | 4.22% | 10 |
|
|
2019
Q3 | $42M | Buy |
198,656
+906
| +0.5% | +$189K | 4.74% | 10 |
|
|
2019
Q2 | $38.4M | Buy |
197,750
+486
| +0.2% | +$89.6K | 4.45% | 10 |
|
|
2019
Q1 | $32.5M | Buy |
197,264
+989
| +0.5% | +$175K | 3.97% | 11 |
|
|
2018
Q4 | $36.9M | Sell |
196,275
-35,606
| -15% | -$6.58M | 5.1% | 10 |
|
|
2018
Q3 | $39.5M | Buy |
231,881
+2,118
| +0.9% | +$357K | 4.69% | 9 |
|
|
2018
Q2 | $37.7M | Buy |
229,763
+1,755
| +0.8% | +$287K | 4.59% | 9 |
|
|
2018
Q1 | $36.9M | Sell |
228,008
-11,076
| -5% | -$1.76M | 4.38% | 9 |
|
|
2017
Q4 | $34.9M | Buy |
239,084
+30,689
| +15% | +$4.37M | 4.34% | 10 |
|
|
2017
Q3 | $28.3M | Buy |
208,395
+17,186
| +9% | +$2.17M | 3.97% | 11 |
|
|
2017
Q2 | $23.9M | Buy |
191,209
+7,127
| +4% | +$852K | 3.64% | 13 |
|
|
2017
Q1 | $21.9M | Buy |
184,082
+3,680
| +2% | +$443K | 3.49% | 11 |
|
|
2016
Q4 | $20.8M | Buy |
180,402
+3,017
| +2% | +$336K | 3.71% | 11 |
|
|
2016
Q3 | $18.5M | Buy |
177,385
+1,184
| +0.7% | +$124K | 3.64% | 13 |
|
|
2016
Q2 | $17.2M | Buy |
+176,201
| New | +$16.7M | 3.6% | 12 |
|
Other funds holding CME
PAM
SP
HCM
CF
OIAM
SI
AAMU
Cooper Investors's CME Position: Q2 2026 in Review
Cooper Investors reduced its CME Group (CME) stake by 42% in Q2 2026, selling an estimated $5.4M and leaving 27,046 shares worth $5.97M. The position accounts for 2.74% of the portfolio, ranked #15.
Cooper Investors first reported a position in CME in Q2 2016 and has held it in 40 quarters since. The position peaked at $64.8M in Q1 2024. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Cooper Investors held 27,046 shares of CME Group worth $5.97M as of Q2 2026.
- Cooper Investors sold 19,506 CME Group shares in Q2 2026, an estimated $5.4M.
- CME Group made up 2.74% of Cooper Investors's portfolio in Q2 2026, its #15 holding.
- Cooper Investors first reported a position in CME Group in Q2 2016 and has held it in 40 quarters since.
- Cooper Investors's CME Group position peaked at $64.8M in Q1 2024.
- 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Cooper Investors's 13F filing for Q2 2026, filed 7 Jul 2026.